| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 2.66e-07 | 4 | 82 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.24e-04 | 188 | 82 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 6.26e-04 | 167 | 82 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | actin binding | SPATA31A1 SPATA31A3 FHOD1 SPATA31A7 LIMCH1 SPATA31A6 SPATA31A5 MTSS2 | 7.80e-04 | 479 | 82 | 8 | GO:0003779 |
| GeneOntologyMolecularFunction | chromatin binding | 8.76e-04 | 739 | 82 | 10 | GO:0003682 | |
| GeneOntologyMolecularFunction | minor groove of adenine-thymine-rich DNA binding | 8.94e-04 | 11 | 82 | 2 | GO:0003680 | |
| GeneOntologyMolecularFunction | dynein light chain binding | 1.07e-03 | 12 | 82 | 2 | GO:0045503 | |
| GeneOntologyCellularComponent | Golgi lumen | MUC3B MUC17 VCAN SDC3 MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC MUC6 | 5.46e-13 | 109 | 83 | 11 | GO:0005796 |
| GeneOntologyCellularComponent | PcG protein complex | 5.41e-05 | 52 | 83 | 4 | GO:0031519 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 9.30e-05 | 4 | 83 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | acrosomal vesicle | 1.71e-04 | 206 | 83 | 6 | GO:0001669 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.67e-04 | 656 | 83 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.74e-04 | 658 | 83 | 10 | GO:0030312 | |
| GeneOntologyCellularComponent | ruffle | 1.38e-03 | 206 | 83 | 5 | GO:0001726 | |
| GeneOntologyCellularComponent | microvillus | 1.47e-03 | 123 | 83 | 4 | GO:0005902 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription repressor complex | 2.04e-03 | 17 | 83 | 2 | GO:0090571 | |
| Domain | SEA | 4.50e-10 | 23 | 79 | 6 | PS50024 | |
| Domain | SEA_dom | 4.50e-10 | 23 | 79 | 6 | IPR000082 | |
| Domain | SEA | 2.31e-09 | 14 | 79 | 5 | SM00200 | |
| Domain | SEA | 2.96e-08 | 22 | 79 | 5 | PF01390 | |
| Domain | DUF4599 | 1.43e-07 | 12 | 79 | 4 | PF15371 | |
| Domain | DUF4599 | 1.43e-07 | 12 | 79 | 4 | IPR027970 | |
| Domain | VWD | 5.19e-07 | 16 | 79 | 4 | SM00216 | |
| Domain | VWF_type-D | 5.19e-07 | 16 | 79 | 4 | IPR001846 | |
| Domain | VWFD | 5.19e-07 | 16 | 79 | 4 | PS51233 | |
| Domain | VWD | 5.19e-07 | 16 | 79 | 4 | PF00094 | |
| Domain | TIL | 1.56e-05 | 12 | 79 | 3 | PF01826 | |
| Domain | C8 | 1.56e-05 | 12 | 79 | 3 | PF08742 | |
| Domain | DYNC1I1/DYNC1I2 | 1.77e-05 | 2 | 79 | 2 | IPR025956 | |
| Domain | Dynein_IC2 | 1.77e-05 | 2 | 79 | 2 | PF11540 | |
| Domain | Unchr_dom_Cys-rich | 2.02e-05 | 13 | 79 | 3 | IPR014853 | |
| Domain | I-BAR_dom | 2.02e-05 | 13 | 79 | 3 | IPR013606 | |
| Domain | C8 | 2.02e-05 | 13 | 79 | 3 | SM00832 | |
| Domain | TIL_dom | 2.56e-05 | 14 | 79 | 3 | IPR002919 | |
| Domain | - | 3.19e-05 | 15 | 79 | 3 | 3.30.70.960 | |
| Domain | VWC_out | 6.72e-05 | 19 | 79 | 3 | SM00215 | |
| Domain | EGF_1 | 1.02e-04 | 255 | 79 | 7 | PS00022 | |
| Domain | CT | 1.06e-04 | 22 | 79 | 3 | SM00041 | |
| Domain | EGF-like_CS | 1.18e-04 | 261 | 79 | 7 | IPR013032 | |
| Domain | EGF_2 | 1.30e-04 | 265 | 79 | 7 | PS01186 | |
| Domain | Cys_knot_C | 1.57e-04 | 25 | 79 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.57e-04 | 25 | 79 | 3 | PS01225 | |
| Domain | IMD | 2.62e-04 | 6 | 79 | 2 | PF08397 | |
| Domain | WxxW_domain | 2.62e-04 | 6 | 79 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.62e-04 | 6 | 79 | 2 | PF13330 | |
| Domain | Hirudin/antistatin | 3.66e-04 | 7 | 79 | 2 | IPR011061 | |
| Domain | EGF_3 | 4.81e-04 | 235 | 79 | 6 | PS50026 | |
| Domain | EGF | 4.81e-04 | 235 | 79 | 6 | SM00181 | |
| Domain | EGF-like_dom | 6.52e-04 | 249 | 79 | 6 | IPR000742 | |
| Domain | VWF_dom | 7.42e-04 | 42 | 79 | 3 | IPR001007 | |
| Domain | Glyco_hormone_CN | 1.79e-03 | 15 | 79 | 2 | IPR006208 | |
| Domain | Cys_knot | 1.79e-03 | 15 | 79 | 2 | PF00007 | |
| Domain | CTCK_1 | 2.59e-03 | 18 | 79 | 2 | PS01185 | |
| Domain | MARVEL | 5.79e-03 | 27 | 79 | 2 | PF01284 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 5.37e-16 | 16 | 57 | 8 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.01e-15 | 17 | 57 | 8 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.00e-14 | 23 | 57 | 8 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 6.32e-14 | 26 | 57 | 8 | M27483 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS12 MUC17 MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC MUC6 NOTCH2 | 1.24e-13 | 68 | 57 | 10 | M27303 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS12 MUC17 VCAN SDC3 MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC MUC6 NOTCH2 | 3.56e-13 | 143 | 57 | 12 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.22e-10 | 62 | 57 | 8 | M546 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.73e-10 | 21 | 57 | 6 | MM15706 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS12 MUC17 VCAN SDC3 MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC MUC6 NOTCH2 | 2.59e-10 | 250 | 57 | 12 | M27554 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 5.50e-10 | 111 | 57 | 9 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 8.49e-08 | 140 | 57 | 8 | M27484 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.41e-07 | 60 | 57 | 6 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.62e-07 | 109 | 57 | 7 | MM15164 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 1.53e-04 | 26 | 57 | 3 | M47923 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.43e-04 | 34 | 57 | 3 | MM15531 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 4.42e-04 | 37 | 57 | 3 | M27797 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 PHC3 MUC17 VCAN MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC MUC6 RXRA DYNC1I1 CBX8 DYNC1I2 | 5.79e-04 | 1475 | 57 | 15 | M19806 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 1.09e-03 | 649 | 57 | 9 | MM15690 | |
| Pathway | KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.22e-03 | 13 | 57 | 2 | M47763 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 3.19e-17 | 18 | 83 | 8 | 18834073 | |
| Pubmed | 4.10e-13 | 6 | 83 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 4.10e-13 | 6 | 83 | 5 | 25930072 | |
| Pubmed | 2.00e-11 | 24 | 83 | 6 | 32212159 | ||
| Pubmed | TBX15 SOX6 KLF12 SP4 TSC22D1 PER3 VEZF1 TOX3 SRF ETV3 PXN ZNF207 PAX6 ZNF236 RXRA DOP1B | 7.55e-11 | 808 | 83 | 16 | 20412781 | |
| Pubmed | 4.51e-10 | 6 | 83 | 4 | 19110483 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 1.31e-08 | 3 | 83 | 3 | 18163520 | |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 10512748 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 17471237 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 14984930 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 5.23e-08 | 4 | 83 | 3 | 29869461 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 23807779 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 12676567 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 1.31e-07 | 5 | 83 | 3 | 11062147 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 1.31e-07 | 5 | 83 | 3 | 16475027 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TBX15 SOX6 KLF12 SP4 TSC22D1 TOX3 SRF ETV3 KMT2A PAX6 ZNF236 RFX7 RXRA | 2.36e-07 | 908 | 83 | 13 | 19274049 |
| Pubmed | CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. | 1.55e-06 | 10 | 83 | 3 | 22094252 | |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.88e-06 | 37 | 83 | 4 | 27565344 | |
| Pubmed | CCNT1 PHC3 MYADM EIF4ENIF1 VEZF1 DSG2 CSNK2A1 SLC5A6 PKP4 PXN KMT2A NUMB ZNF207 LIMCH1 CBX8 | 2.32e-06 | 1497 | 83 | 15 | 31527615 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 4.80e-06 | 180 | 83 | 6 | 35198878 | |
| Pubmed | 4.97e-06 | 47 | 83 | 4 | 11208732 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 7513696 | ||
| Pubmed | Cloning and characterization of two cytoplasmic dynein intermediate chain genes in mouse and human. | 5.63e-06 | 2 | 83 | 2 | 10049579 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 34058148 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 5.63e-06 | 2 | 83 | 2 | 14988081 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 15563276 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 18782111 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12958310 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17621824 | ||
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 5.63e-06 | 2 | 83 | 2 | 18475301 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22220206 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24317696 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 22391959 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 5.63e-06 | 2 | 83 | 2 | 35776514 | |
| Pubmed | Three-dimensional atomic structure of a catalytic subunit mutant of human protein kinase CK2. | 5.63e-06 | 2 | 83 | 2 | 14646071 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24327612 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 5.63e-06 | 2 | 83 | 2 | 21653907 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28321513 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 2046671 | ||
| Pubmed | Assignment of casein kinase 2 alpha sequences to two different human chromosomes. | 5.63e-06 | 2 | 83 | 2 | 1577469 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9422745 | ||
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 5.63e-06 | 2 | 83 | 2 | 36427316 | |
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 5.63e-06 | 2 | 83 | 2 | 28607090 | |
| Pubmed | Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. | 5.63e-06 | 2 | 83 | 2 | 10973822 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 12360467 | ||
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 5.63e-06 | 2 | 83 | 2 | 23272068 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28112683 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 5.63e-06 | 2 | 83 | 2 | 27729120 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 9334251 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 5.63e-06 | 2 | 83 | 2 | 23527003 | |
| Pubmed | Crystal structure of a C-terminal deletion mutant of human protein kinase CK2 catalytic subunit. | 5.63e-06 | 2 | 83 | 2 | 12860116 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16540890 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 36111525 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 5.63e-06 | 2 | 83 | 2 | 27845589 | |
| Pubmed | Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. | 5.63e-06 | 2 | 83 | 2 | 2393399 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11289722 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27435107 | ||
| Pubmed | Binding of dynein intermediate chain 2 to paxillin controls focal adhesion dynamics and migration. | 5.63e-06 | 2 | 83 | 2 | 22553211 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23544943 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26871672 | ||
| Pubmed | Molecular cloning of the human casein kinase II alpha subunit. | 5.63e-06 | 2 | 83 | 2 | 2752008 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11988092 | ||
| Pubmed | Structure and sequence of an intronless gene for human casein kinase II-alpha subunit. | 5.63e-06 | 2 | 83 | 2 | 8420794 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 14690056 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 5.63e-06 | 2 | 83 | 2 | 32348677 | |
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 5.63e-06 | 2 | 83 | 2 | 11587997 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28649694 | ||
| Pubmed | Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice. | 5.63e-06 | 2 | 83 | 2 | 19158956 | |
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 5.63e-06 | 2 | 83 | 2 | 24722639 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20657784 | ||
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 5.63e-06 | 2 | 83 | 2 | 24332705 | |
| Pubmed | The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. | 5.63e-06 | 2 | 83 | 2 | 10405327 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 5.63e-06 | 2 | 83 | 2 | 34656442 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DSG2 KIAA0232 KMT2A NUMB LIMCH1 RFX7 HECTD1 NOTCH2 MTSS2 DOP1B CCSER1 | 6.40e-06 | 861 | 83 | 11 | 36931259 |
| Pubmed | Primary cilia maintain corneal epithelial homeostasis by regulation of the Notch signaling pathway. | 1.24e-05 | 19 | 83 | 3 | 27122169 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23446997 | ||
| Pubmed | Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation. | 1.69e-05 | 3 | 83 | 2 | 15684395 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 33232357 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 27776277 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23053434 | ||
| Pubmed | Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression. | 1.69e-05 | 3 | 83 | 2 | 23305535 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 2174700 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 29286856 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 27230679 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 30236127 | ||
| Pubmed | Mucin expression in reactive gastropathy: an immunohistochemical analysis. | 1.69e-05 | 3 | 83 | 2 | 17227128 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 36675209 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 23828549 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 1.69e-05 | 3 | 83 | 2 | 17592322 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 1766873 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 29802623 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 28052864 | ||
| Pubmed | Casein kinase II phosphorylation increases the rate of serum response factor-binding site exchange. | 1.69e-05 | 3 | 83 | 2 | 1740119 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26770020 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18825309 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 34111112 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20065027 | ||
| Interaction | PCGF5 interactions | 3.04e-06 | 101 | 80 | 6 | int:PCGF5 | |
| Interaction | FBRS interactions | 3.22e-06 | 102 | 80 | 6 | int:FBRS | |
| Interaction | DYNLT1 interactions | 5.14e-06 | 241 | 80 | 8 | int:DYNLT1 | |
| Interaction | HAGHL interactions | 1.67e-05 | 13 | 80 | 3 | int:HAGHL | |
| Interaction | CLASP1 interactions | 1.83e-05 | 138 | 80 | 6 | int:CLASP1 | |
| Interaction | PCGF1 interactions | 1.89e-05 | 208 | 80 | 7 | int:PCGF1 | |
| Interaction | NCOA6 interactions | 2.43e-05 | 145 | 80 | 6 | int:NCOA6 | |
| Interaction | PCGF3 interactions | 2.93e-05 | 90 | 80 | 5 | int:PCGF3 | |
| Interaction | KDM2B interactions | 4.37e-05 | 161 | 80 | 6 | int:KDM2B | |
| Interaction | DTX2 interactions | 4.94e-05 | 330 | 80 | 8 | int:DTX2 | |
| Interaction | NFYC interactions | 7.40e-05 | 177 | 80 | 6 | int:NFYC | |
| Interaction | BMAL1 interactions | 8.01e-05 | 111 | 80 | 5 | int:BMAL1 | |
| Interaction | NIN interactions | 8.90e-05 | 359 | 80 | 8 | int:NIN | |
| Interaction | DCAF7 interactions | 1.06e-04 | 368 | 80 | 8 | int:DCAF7 | |
| Interaction | TLE3 interactions | 1.23e-04 | 376 | 80 | 8 | int:TLE3 | |
| Interaction | ZDHHC15 interactions | 1.40e-04 | 125 | 80 | 5 | int:ZDHHC15 | |
| Interaction | ARID4B interactions | 1.41e-04 | 199 | 80 | 6 | int:ARID4B | |
| Interaction | RING1 interactions | 1.49e-04 | 201 | 80 | 6 | int:RING1 | |
| Interaction | HTN1 interactions | 1.54e-04 | 5 | 80 | 2 | int:HTN1 | |
| Interaction | ALB interactions | 1.60e-04 | 391 | 80 | 8 | int:ALB | |
| Interaction | DPY30 interactions | 1.61e-04 | 204 | 80 | 6 | int:DPY30 | |
| Interaction | ZHX2 interactions | 1.64e-04 | 69 | 80 | 4 | int:ZHX2 | |
| Cytoband | 7q22 | 4.59e-05 | 38 | 83 | 3 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 8.98e-05 | 8 | 83 | 2 | chr9q12 | |
| Cytoband | 11q22.1 | 2.90e-04 | 14 | 83 | 2 | 11q22.1 | |
| Cytoband | 11p15.3 | 6.63e-04 | 21 | 83 | 2 | 11p15.3 | |
| Cytoband | 9p13.1 | 8.69e-04 | 24 | 83 | 2 | 9p13.1 | |
| Cytoband | 11p15.5 | 1.31e-03 | 118 | 83 | 3 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 3.64e-03 | 564 | 83 | 5 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p12 | 4.19e-03 | 53 | 83 | 2 | chr1p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 4.53e-03 | 183 | 83 | 3 | chr16q22 | |
| GeneFamily | CD molecules|Mucins | 3.20e-18 | 21 | 55 | 9 | 648 | |
| GeneFamily | Dyneins, cytoplasmic | 6.94e-04 | 13 | 55 | 2 | 538 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.57e-09 | 170 | 80 | 9 | M5880 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.56e-07 | 158 | 80 | 7 | MM17063 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_DN | 3.25e-05 | 198 | 80 | 6 | M9530 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SECISBP2L PHC3 TSC22D1 PER3 CSNK2A1 PKP4 ASAP3 ZNF207 LIMCH1 HECTD1 CLIP1 | 3.33e-05 | 807 | 80 | 11 | M16651 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL | 3.92e-05 | 62 | 80 | 4 | M45790 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 4.28e-05 | 208 | 80 | 6 | M39233 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 IGSF10 MUC17 VCAN SDC3 MUC16 MUC5B MUC12 MUC3A MUC4 MUC5AC MUC6 | 6.28e-05 | 1026 | 80 | 12 | M5889 |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 5.67e-11 | 183 | 82 | 9 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SECISBP2L ARHGAP42 TOX3 TMEM63C MUC16 MUC5B LIMCH1 MUC4 MUC5AC | 1.00e-10 | 195 | 82 | 9 | e7230a849ea31e6eef9bc6f5468938499450582d |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.56e-09 | 200 | 82 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.15e-08 | 179 | 82 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.31e-08 | 180 | 82 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.31e-08 | 180 | 82 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 5.01e-08 | 184 | 82 | 7 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.24e-08 | 190 | 82 | 7 | 23f2ac4da431211084bb6ab0494c2e0b69547cb6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.24e-08 | 190 | 82 | 7 | 3c337374d89e69cc0a78e65a4a7e21db7b050fcd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.19e-08 | 194 | 82 | 7 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.85e-08 | 200 | 82 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.94e-07 | 179 | 82 | 6 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-07 | 179 | 82 | 6 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-06 | 180 | 82 | 6 | 8ba9bba0c9fecf184a4332ba4585fb2439f68cd3 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 180 | 82 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 180 | 82 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-06 | 182 | 82 | 6 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 1.13e-06 | 183 | 82 | 6 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-06 | 183 | 82 | 6 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-06 | 184 | 82 | 6 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 189 | 82 | 6 | 6c71e81373cb7822de23c193a6350b6df9f567bc | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.36e-06 | 189 | 82 | 6 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.41e-06 | 190 | 82 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-06 | 191 | 82 | 6 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-06 | 193 | 82 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-06 | 195 | 82 | 6 | fc2a1d84b3d013e5cb9e7b9cdd740e4010897d20 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.68e-06 | 196 | 82 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.79e-06 | 198 | 82 | 6 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 1.84e-06 | 199 | 82 | 6 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-06 | 199 | 82 | 6 | 57709dc893da8d9333830b8277a6d92e25aa8bc0 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 1.84e-06 | 199 | 82 | 6 | 95403988caef322314f4ed15415ad1a9a987adc1 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.84e-06 | 199 | 82 | 6 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells-Malignant_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.89e-06 | 200 | 82 | 6 | 5e2def2e56f21bc7295cdcf3580f5c0d16a6a494 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-Neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | b9538eb33ac86384e7e289a5a82fac4d56a7b9c2 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.89e-06 | 200 | 82 | 6 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.89e-06 | 200 | 82 | 6 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.89e-06 | 200 | 82 | 6 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.12e-06 | 135 | 82 | 5 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-06 | 145 | 82 | 5 | 9964d6d3769be2f35d86268fe044cecd1d5a1616 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.32e-05 | 164 | 82 | 5 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 166 | 82 | 5 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-05 | 173 | 82 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 174 | 82 | 5 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.75e-05 | 174 | 82 | 5 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-05 | 178 | 82 | 5 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 178 | 82 | 5 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 178 | 82 | 5 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | 15-Trachea-Epithelial-Goblet-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 1.95e-05 | 178 | 82 | 5 | f0557920b9b3e7c4f39938d1b524aa58711af4d2 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 178 | 82 | 5 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.01e-05 | 179 | 82 | 5 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.06e-05 | 180 | 82 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Control-Epithelial-Goblet|Control / Disease state, Lineage and Cell class | 2.06e-05 | 180 | 82 | 5 | 5293d23b8b8ea587239ffde561b70bad01632521 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.12e-05 | 181 | 82 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 182 | 82 | 5 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 182 | 82 | 5 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.17e-05 | 182 | 82 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 182 | 82 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 182 | 82 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-05 | 185 | 82 | 5 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.35e-05 | 185 | 82 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-05 | 185 | 82 | 5 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.41e-05 | 186 | 82 | 5 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 2.41e-05 | 186 | 82 | 5 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 188 | 82 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 188 | 82 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.60e-05 | 189 | 82 | 5 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 189 | 82 | 5 | 1cfc1fe27c4b57b4e52700fa8f679ce172cee5a9 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.60e-05 | 189 | 82 | 5 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 189 | 82 | 5 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Control-Epithelial-Basal/Club|Control / Disease group,lineage and cell class (2021.01.30) | 2.67e-05 | 190 | 82 | 5 | 799b0b1c4bdbe04ee0fc34d0be9e02b5992774a0 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 190 | 82 | 5 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 190 | 82 | 5 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 2.67e-05 | 190 | 82 | 5 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.67e-05 | 190 | 82 | 5 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 190 | 82 | 5 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.74e-05 | 191 | 82 | 5 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.74e-05 | 191 | 82 | 5 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 192 | 82 | 5 | c312e39003c51503c9f648332fb5c6218f33f99b | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 2.81e-05 | 192 | 82 | 5 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 2.81e-05 | 192 | 82 | 5 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 2.81e-05 | 192 | 82 | 5 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 192 | 82 | 5 | 133b3ad251d72ff31e45e1dc6217945516ac63de | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 193 | 82 | 5 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-05 | 193 | 82 | 5 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.88e-05 | 193 | 82 | 5 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 193 | 82 | 5 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 193 | 82 | 5 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 193 | 82 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 193 | 82 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-05 | 193 | 82 | 5 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.88e-05 | 193 | 82 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.88e-05 | 193 | 82 | 5 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | COPD-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 2.95e-05 | 194 | 82 | 5 | 72a2e0cba171ab59aa176e91a59a54c562af0390 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-05 | 194 | 82 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.95e-05 | 194 | 82 | 5 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-05 | 194 | 82 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.02e-05 | 195 | 82 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.02e-05 | 195 | 82 | 5 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | normal_Lung-Epithelial_cells-Club|normal_Lung / Location, Cell class and cell subclass | 3.02e-05 | 195 | 82 | 5 | b46544ad5af04f4dbc2643637caa3d2d50d922ae | |
| Drug | cellobiitol | 3.07e-09 | 37 | 79 | 6 | CID000003871 | |
| Drug | rioprostil | 8.28e-08 | 32 | 79 | 5 | CID005311413 | |
| Drug | guanidine hydrochloride | 3.29e-07 | 129 | 79 | 7 | CID000005742 | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; PC3; HT_HG-U133A | 4.20e-07 | 197 | 79 | 8 | 2082_DN | |
| Drug | Gastrin tetrapeptide | 8.29e-07 | 50 | 79 | 5 | CID000005415 | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 4.25e-06 | 189 | 79 | 7 | 2231_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 5.40e-06 | 196 | 79 | 7 | 2221_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 5.40e-06 | 196 | 79 | 7 | 3571_UP | |
| Drug | inulin | 6.95e-06 | 133 | 79 | 6 | CID000024763 | |
| Drug | mucic acid | 1.38e-05 | 88 | 79 | 5 | CID000000607 | |
| Drug | Tn epitope | 4.00e-05 | 55 | 79 | 4 | CID000447272 | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | 5.55e-05 | 192 | 79 | 6 | 1365_DN | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.87e-05 | 194 | 79 | 6 | 4828_UP | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A | 5.87e-05 | 194 | 79 | 6 | 1715_DN | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 6.04e-05 | 195 | 79 | 6 | 4162_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A | 6.04e-05 | 195 | 79 | 6 | 2071_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 3350_UP | |
| Drug | STOCK1N-35696; Down 200; 15uM; MCF7; HT_HG-U133A | 6.40e-05 | 197 | 79 | 6 | 6577_DN | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 4422_UP | |
| Drug | (-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 6.58e-05 | 198 | 79 | 6 | 2772_UP | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 6.76e-05 | 199 | 79 | 6 | 4352_DN | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.76e-05 | 199 | 79 | 6 | 4381_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A | 6.76e-05 | 199 | 79 | 6 | 3017_DN | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 6.95e-05 | 200 | 79 | 6 | 3904_DN | |
| Drug | Condelphine [7633-69-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 6.95e-05 | 200 | 79 | 6 | 3538_UP | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.50e-08 | 61 | 79 | 6 | DOID:3587 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.01e-08 | 64 | 79 | 6 | DOID:4947 (is_marker_for) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.84e-07 | 5 | 79 | 3 | DOID:3030 (is_marker_for) | |
| Disease | keratoconjunctivitis (is_marker_for) | 2.12e-05 | 3 | 79 | 2 | DOID:9368 (is_marker_for) | |
| Disease | Hyaloideoretinal degeneration of Wagner | 4.23e-05 | 4 | 79 | 2 | C1840452 | |
| Disease | X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance (implicated_via_orthology) | 4.23e-05 | 4 | 79 | 2 | DOID:0080311 (implicated_via_orthology) | |
| Disease | multisite chronic pain | 1.26e-04 | 95 | 79 | 4 | EFO_0010100 | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 1.47e-04 | 7 | 79 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | neurotic disorder | 1.60e-04 | 101 | 79 | 4 | EFO_0004257 | |
| Disease | pancreatic cancer (is_marker_for) | 1.60e-04 | 101 | 79 | 4 | DOID:1793 (is_marker_for) | |
| Disease | common bile duct neoplasm (is_marker_for) | 1.96e-04 | 8 | 79 | 2 | DOID:4608 (is_marker_for) | |
| Disease | osteoarthritis, spine, body mass index | 1.96e-04 | 8 | 79 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | dry eye syndrome (is_marker_for) | 3.14e-04 | 10 | 79 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 3.14e-04 | 10 | 79 | 2 | DOID:10754 (is_marker_for) | |
| Disease | pulmonary fibrosis | 3.83e-04 | 11 | 79 | 2 | EFO_0009448 | |
| Disease | plasminogen activator inhibitor 1 measurement | 4.15e-04 | 54 | 79 | 3 | EFO_0004792 | |
| Disease | gastric ulcer (implicated_via_orthology) | 6.31e-04 | 14 | 79 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | neuroticism measurement | 7.19e-04 | 909 | 79 | 9 | EFO_0007660 | |
| Disease | otitis media (biomarker_via_orthology) | 9.38e-04 | 17 | 79 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | QRS duration | 1.24e-03 | 298 | 79 | 5 | EFO_0005055 | |
| Disease | Sjogren's syndrome (is_marker_for) | 1.88e-03 | 24 | 79 | 2 | DOID:12894 (is_marker_for) | |
| Disease | brain cancer (implicated_via_orthology) | 2.21e-03 | 26 | 79 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | white matter integrity, age at assessment | 2.21e-03 | 26 | 79 | 2 | EFO_0004641, EFO_0008007 | |
| Disease | red blood cell density measurement | 2.45e-03 | 880 | 79 | 8 | EFO_0007978 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 2.57e-03 | 352 | 79 | 5 | EFO_0007014 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSPIIQSVGSTSSSP | 1036 | Q99569 | |
| VPSDMSSTISTNTPS | 196 | P59817 | |
| ESLGSPASSSSLMSP | 791 | Q8TDY4 | |
| SEGPSSTMVSTSAFP | 1986 | P13611 | |
| VSSFSSGPTSPSEMP | 321 | O60239 | |
| SVGAMPLPSSTITSS | 2141 | Q8IZF6 | |
| SSEESAPVTTPTMAS | 361 | P41162 | |
| ADMSPASSTTSLPVS | 646 | Q9C0I3 | |
| SMSTSTTSAVPSLPV | 301 | O60563 | |
| TSPMSDLPLTSETSS | 716 | Q9C0F0 | |
| MLTTPTGPESMSTST | 1031 | P58397 | |
| TGPESMSTSTPAISS | 1036 | P58397 | |
| MSTSTPAISSPSPTT | 1041 | P58397 | |
| SQTTTPTATMSTATP | 1996 | Q9HC84 | |
| PTATMSTATPSSTPE | 2001 | Q9HC84 | |
| SMATPSSSTQTSGTP | 2116 | Q9HC84 | |
| STPATSSTAMPSSTP | 2416 | Q9HC84 | |
| SSTAMPSSTPGTTWI | 2421 | Q9HC84 | |
| TTPTATMSTATPSST | 2556 | Q9HC84 | |
| TRATSSMSTPSSTPG | 3116 | Q9HC84 | |
| SMSTPSSTPGTTWIL | 3121 | Q9HC84 | |
| TTPTATMSTATPSST | 3256 | Q9HC84 | |
| QTTTPTATMSTATPS | 3811 | Q9HC84 | |
| TATMSTATPSSTPET | 3816 | Q9HC84 | |
| MATPSSSTQTSGTPP | 3931 | Q9HC84 | |
| TPATSSTAMPSSTPG | 4231 | Q9HC84 | |
| ATMSTIHPSSTPETT | 4346 | Q9HC84 | |
| TTPTATMSTATPSST | 4541 | Q9HC84 | |
| MPTATASTVPSSSTV | 4886 | Q9HC84 | |
| FSSTVPSTASPMNTV | 171 | Q9NTZ6 | |
| TETSYVTGSTMPPTT | 936 | Q14126 | |
| QPTTPVSSFTSGSML | 301 | P26367 | |
| SEGASSFSPLSMSSP | 411 | Q8IYW4 | |
| SSPSSPTPKVTMSST | 1156 | Q8WXI7 | |
| STDLDISSPSSPMST | 1471 | Q8WXI7 | |
| PIGTSSPAETSTNMA | 1651 | Q8WXI7 | |
| EGSQMSTSIPLTSSP | 1741 | Q8WXI7 | |
| ISPTSISGMTASSSP | 2391 | Q8WXI7 | |
| SPAGTSPGSPEMSTT | 3191 | Q8WXI7 | |
| MTTDTLGTSPEPTTS | 6841 | Q8WXI7 | |
| TSSPVTTTDMLHTSP | 7131 | Q8WXI7 | |
| SDSETPKATSPMGTT | 8371 | Q8WXI7 | |
| FSLSSPVMTSSSPVS | 9146 | Q8WXI7 | |
| TSIPGPAQSTMSSDT | 9331 | Q8WXI7 | |
| TMPSTVTSPEAESSS | 11291 | Q8WXI7 | |
| STHPGTETSTMIPTS | 11851 | Q8WXI7 | |
| TTPGMSTLASESVTS | 12006 | Q8WXI7 | |
| FTHRSSMPTTSTPGT | 12191 | Q8WXI7 | |
| SMPTTSTPGTSTVDV | 12196 | Q8WXI7 | |
| SPMTDTKTVTTPGSS | 656 | Q99102 | |
| TSLSSASTGDTMPLP | 1316 | Q99102 | |
| TNTSSVSTGDTMPLP | 3396 | Q99102 | |
| RTTMTLPTPATSGTS | 1326 | Q6W4X9 | |
| GSSPFSSTGPMTATS | 1581 | Q6W4X9 | |
| TGTPPMTVTTSGTSQ | 1721 | Q6W4X9 | |
| TAPPMTPTTSGTSQS | 1891 | Q6W4X9 | |
| SPFSSTGPMTATSFQ | 1976 | Q6W4X9 | |
| GSTHTAPPMTVTTSG | 2056 | Q6W4X9 | |
| APPMTVTTSGTSQTH | 2061 | Q6W4X9 | |
| VSDTTSSPMITSPGI | 2161 | Q04721 | |
| MAPGSVTSDISPSST | 1 | Q8IZA3 | |
| TSTGTTGPPVTMTTG | 196 | P16150 | |
| CEESSTPGTTAASMP | 1046 | Q9NQ38 | |
| MPPSYLDTESTSGTS | 541 | Q9Y3R5 | |
| MPTSPSSEQVGEATS | 461 | P56696 | |
| MSPSSKSVSTPSEAG | 96 | O14576 | |
| MSPSSKSVSTPSEAG | 86 | Q13409 | |
| FDMEPSSTSSTPTSL | 726 | Q9P1W3 | |
| SSAISPSMSSAMSPT | 876 | P56645 | |
| SSSSSYPGPVSVSEM | 16 | Q92628 | |
| PPSSPSSSSSRKSSM | 261 | Q765P7 | |
| SMTGTLSTETSLPPT | 356 | Q02505 | |
| SSSLPTTETATTPMT | 371 | Q02505 | |
| STTMTPSSLSTDIPF | 431 | Q02505 | |
| SSSAMSTSVIPSSPS | 476 | Q02505 | |
| TSFTTSTTMEPPSTT | 576 | Q02505 | |
| STTMEPPSTTAATTG | 581 | Q02505 | |
| TTTPTPTTDMSTESL | 611 | Q02505 | |
| TTAMTSPPITSSVTS | 626 | Q02505 | |
| SMTTTTSPPTTTNSF | 646 | Q02505 | |
| LPTPNASSMTTSETT | 696 | Q02505 | |
| TMTETSSTATSLPPT | 731 | Q02505 | |
| ISISVSMTSATTPSG | 871 | Q02505 | |
| SMTSATTPSGGPTFT | 876 | Q02505 | |
| STMMEPPSSTVSTTG | 956 | Q02505 | |
| TTAMTSPPPVSSSIT | 1001 | Q02505 | |
| TSSSLPTTETATMTP | 1121 | Q02505 | |
| MTPSSLSTDTPSTTP | 1186 | Q02505 | |
| TTTSFTTSPTMEPPS | 1326 | Q02505 | |
| SLTTAMTSTPPITSS | 1376 | Q02505 | |
| MSATTPSGGPTFTST | 1631 | Q02505 | |
| STPSFTSSITTSEMP | 2106 | Q02505 | |
| ETSSLVGTTSPTMST | 2536 | Q02505 | |
| LPSSGTSTPSSMVDI | 601 | Q6ZNL6 | |
| TTTTTSSSGLGSPMI | 11 | Q96S97 | |
| PATSTSSMSTTAPGT | 1546 | P98088 | |
| PPVPATSTSSMSTTA | 1916 | P98088 | |
| APTTRTTSAPTSSMT | 4276 | P98088 | |
| TTSAPTSSMTSGPGT | 4281 | P98088 | |
| TSSMTSGPGTTPSPV | 4286 | P98088 | |
| PTTSTTSAPITSMTS | 4461 | P98088 | |
| TSAPITSMTSGPGTT | 4466 | P98088 | |
| MDTEPNPGTSSVSTT | 1 | Q8NDX5 | |
| SAEPSPTVMSTSLGS | 126 | P49023 | |
| PTAASNTTTPGMVST | 91 | Q8N131 | |
| SSSMPGGSTPVSSAN | 336 | Q8NEV1 | |
| FPNLTTPGTTSTVTM | 1596 | Q9ULT8 | |
| SPDQSSGFTTPTAMT | 1361 | Q6WRI0 | |
| NMGLSPPASSTSTSS | 126 | Q9HC52 | |
| SSSMPGGSTPVSSAN | 336 | P68400 | |
| ASSSTPIEGSPMTLT | 196 | Q96P31 | |
| TSPTAVSSSPVSMTA | 91 | Q9Y4X4 | |
| VSSSPVSMTASASSP | 96 | Q9Y4X4 | |
| MQTTTTPTSSASVPG | 3346 | Q03164 | |
| SSSPIMPTVGPSTAS | 1076 | Q9Y613 | |
| SASLTSQEPSMGSEP | 376 | Q8NDH6 | |
| PTMTTTSTVPASTAT | 171 | Q8N1N2 | |
| TTMATTAATSTGDPT | 161 | O75056 | |
| SMSVPTTPTLGFSTG | 76 | P19793 | |
| TSTASMVSSSPSTPS | 151 | P30622 | |
| SMSAGSGSPSKTVTP | 516 | Q9UPQ0 | |
| DTPGVSSTRMTPTES | 101 | Q685J3 | |
| TSSPTTPEGTDVPMS | 136 | Q685J3 | |
| NSEGSTPLTSMPAST | 211 | Q685J3 | |
| EGSTPLTSTPASTMP | 331 | Q685J3 | |
| TPSEGSTPLTSMPVS | 446 | Q685J3 | |
| SMPVSTTPVASSEAS | 456 | Q685J3 | |
| AEVNSMPTSTPSEGS | 496 | Q685J3 | |
| MPTSTPSEGSTPLTS | 501 | Q685J3 | |
| PSEGSTPLTSMSVST | 506 | Q685J3 | |
| TSMPTSTYTEGSTPL | 676 | Q685J3 | |
| SSSPTTADGASMPTS | 726 | Q685J3 | |
| SMPTSTPSEGSTPLT | 736 | Q685J3 | |
| TPSEGSTPLTSMPVS | 741 | Q685J3 | |
| CSPTTTEGTSMPIST | 786 | Q685J3 | |
| TEGTSMPISTPSEGS | 791 | Q685J3 | |
| TEVSSSPTPAEGTSM | 841 | Q685J3 | |
| EARSSPTTSEGTSMP | 901 | Q685J3 | |
| PTTSEGTSMPTSTPG | 906 | Q685J3 | |
| EGSTPLTSMPDSTTP | 921 | Q685J3 | |
| TAEGTSMPTSTPSEG | 1026 | Q685J3 | |
| SMPTSTPSEGSTPLT | 1031 | Q685J3 | |
| MPTSTYSEGSTPLTS | 1091 | Q685J3 | |
| SEGTTPLASMPVSTT | 1156 | Q685J3 | |
| VTSMPTSTPGERSTP | 1206 | Q685J3 | |
| SSSPTPAEGTSMPTS | 1316 | Q685J3 | |
| TEVSSSPTPAEGTSM | 1666 | Q685J3 | |
| EARSSPTTSEGTSMP | 1726 | Q685J3 | |
| PTTSEGTSMPNSTPS | 1731 | Q685J3 | |
| SSPTTADGSSMPTST | 1906 | Q685J3 | |
| SEGSTPLTSMPLSTT | 1981 | Q685J3 | |
| SSPIPTEGTSMQTST | 2141 | Q685J3 | |
| SPTTSEGTSMPTSTP | 2201 | Q685J3 | |
| EGTSMPTSTPSEGST | 2206 | Q685J3 | |
| PTSTPSEGSTPFTSM | 2211 | Q685J3 | |
| PTAEGTSMPTSTSSE | 2321 | Q685J3 | |
| TSMPTSTSSEGNTPL | 2326 | Q685J3 | |
| GSSPTTADDTSMPTS | 2376 | Q685J3 | |
| SMPTSTYSEGSTPLT | 2386 | Q685J3 | |
| LSTTPVDTSTPMTTS | 2476 | Q685J3 | |
| PMTTSTEASSSPTTA | 2486 | Q685J3 | |
| TSSSPTTAKDTSMPI | 2611 | Q685J3 | |
| SSSPTTAEGSSMPTS | 2671 | Q685J3 | |
| SPTTAEVTSMPTSTP | 2791 | Q685J3 | |
| EVTSMPTSTPSETST | 2796 | Q685J3 | |
| PTSTPSETSTPLTSM | 2801 | Q685J3 | |
| GSSSPTTAEGTSMPI | 2906 | Q685J3 | |
| TTAEGTSMPISTPSE | 2911 | Q685J3 | |
| SSSPTTAEGTSMPIS | 2966 | Q685J3 | |
| TEVSSSPTPAEGTSM | 3081 | Q685J3 | |
| PTTSEGTSMPTSTPS | 3146 | Q685J3 | |
| GTSMPTSTPSEGSTP | 3151 | Q685J3 | |
| SSPPTAEGTSMPTST | 3261 | Q685J3 | |
| AEGTSMPTSTPSEGS | 3266 | Q685J3 | |
| MPTSTPSEGSTPLTS | 3271 | Q685J3 | |
| PSEGSTPLTSMPVST | 3276 | Q685J3 | |
| TSSPSEGTTPLASMP | 3391 | Q685J3 | |
| NSSPTTAEVTSMPTS | 3496 | Q685J3 | |
| SMPTSTAGEGSTPLT | 3506 | Q685J3 | |
| GSSSPTTLEGTTTMP | 3791 | Q685J3 | |
| SPTSPTSDATTSLEM | 241 | P49757 | |
| TSPVPTTVTFGSMDS | 506 | Q9H195 | |
| GSKPTSHMTATTPET | 1116 | Q8NET4 | |
| VSTPTNTTTSASTMP | 301 | Q02446 | |
| NTTTSASTMPESPSS | 306 | Q02446 | |
| ASTMPESPSSSTTCT | 311 | Q02446 | |
| SSQSETPTPTVSMSL | 716 | Q5HYW2 | |
| SYSSSPDSTPMGSIE | 621 | A6NI28 | |
| ASTPSPGPMTTSVSS | 166 | Q5VVP1 | |
| PGPMTTSVSSLSASQ | 171 | Q5VVP1 | |
| MSVGVSTSAPLSPTS | 1 | Q9Y289 | |
| ASTPSPGPMTTSVSS | 166 | Q8IWB4 | |
| PGPMTTSVSSLSASQ | 171 | Q8IWB4 | |
| SGTTSATQPSETFMP | 426 | Q96SF7 | |
| SAPSSPMPTSSTSSD | 681 | Q9UNA1 | |
| PMPTSSTSSDSSPVR | 686 | Q9UNA1 | |
| SPASSGIGSPMASST | 651 | Q93073 | |
| PTSAVSSSGSPASVM | 276 | Q15714 | |
| SVTSQVSSTGPSGMP | 831 | Q15714 | |
| SSPSRSSTATSMDPL | 1391 | A1L4H1 | |
| TAPSTSTTMQVSSGP | 281 | P11831 | |
| STTMQVSSGPSFPIT | 286 | P11831 | |
| TTTPSPQMTSDCSST | 751 | P35712 | |
| ASITSMLSPSFTPTS | 686 | Q9NRA8 | |
| LGSSTPVFSMSSPIS | 1296 | Q8IZF2 | |
| STSMISGASSPYQPT | 16 | Q8IZR5 | |
| ASTPSPGPMTTSVSS | 166 | Q5VYP0 | |
| PGPMTTSVSSLSASQ | 171 | Q5VYP0 | |
| TNPSSSASTTAMPVT | 146 | Q14119 | |
| ASTPSPGPMTTSVSS | 166 | Q5TZJ5 | |
| PGPMTTSVSSLSASQ | 171 | Q5TZJ5 | |
| ASTPSPGPMTTSVSS | 166 | Q5VU36 | |
| PGPMTTSVSSLSASQ | 171 | Q5VU36 | |
| SVTPGAPMSSHTSST | 821 | Q2KHR2 | |
| TTMVGSAPSTQVSPS | 421 | O15405 | |
| PSAGQMGTPVTSSST | 256 | O43670 | |
| LNTTSGSLPSTTPMS | 1531 | Q9UL36 | |
| PSSPIMVDNDSSGTS | 296 | Q96RS0 | |
| GDSTPSPISSGSMET | 606 | Q9UKN1 | |
| GSMETTALPGSTTTP | 946 | Q9UKN1 | |
| SPTTTLSPASMTSLG | 2336 | Q9UKN1 | |
| PTTTLSPASMTSLGV | 2811 | Q9UKN1 | |
| GSMETTALPGSTTTP | 3586 | Q9UKN1 | |
| TTAFPSSTTMPGVSQ | 4371 | Q9UKN1 | |
| PGSMETTLASTATTP | 4861 | Q9UKN1 | |
| SPASMTSSSISGEPT | 4896 | Q9UKN1 |